Form4insider filings, from the source

Insider holders · CIK 0001717452

Odonate Therapeutics, Inc. · ODT

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
John G LemkeyChief Operating Officer1,26113,086,03813,087,299Mar 11, 2019 · 5:42 pm EDTForm 4
Michael S HearneChief Financial Officer87413,086,03813,086,912Mar 11, 2019 · 5:42 pm EDTForm 4
TANG CAPITAL MANAGEMENT LLC10% Owner—13,086,03813,086,038Mar 11, 2019 · 5:42 pm EDTForm 4
TANG CAPITAL PARTNERS LP10% Owner—13,086,03813,086,038Mar 11, 2019 · 5:42 pm EDTForm 4
Kevin C TangChief Executive Officer—13,086,03813,086,038Mar 11, 2019 · 5:42 pm EDTForm 4
Aaron I. DavisDirector645,7562,978,7623,624,518Dec 27, 2018 · 5:01 pm ESTForm 4
Odonate Holdings, LLC10% Owner3,085,687—3,085,687Dec 6, 2017 · 8:05 pm ESTForm 3
Boxer Capital, LLCDirector2,978,762—2,978,762Dec 27, 2018 · 5:00 pm ESTForm 4
Boxer Asset Management Inc.10% Owner2,978,762—2,978,762Dec 27, 2018 · 5:00 pm ESTForm 4
Joseph Lewis10% Owner2,978,762—2,978,762Dec 27, 2018 · 5:00 pm ESTForm 4
Jeff L VacircaDirector4,000—4,000Mar 7, 2019 · 4:57 pm ESTForm 4
Joseph P O'ConnellChief Medical Officer862—862Mar 4, 2019 · 4:47 pm ESTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.